Open Label Study to Assess the Efficacy, Safety and Dosing of Clevidipine in Pediatric Patients Undergoing Surgery

Trial Profile

Open Label Study to Assess the Efficacy, Safety and Dosing of Clevidipine in Pediatric Patients Undergoing Surgery

Suspended
Phase of Trial: Phase IV

Latest Information Update: 18 May 2017

At a glance

  • Drugs Clevidipine (Primary)
  • Indications Perioperative hypertension
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms PIONEER
  • Sponsors Chiesi USA; The Medicines Company
  • Most Recent Events

    • 12 May 2017 Planned End Date changed from 1 Feb 2016 to 1 Dec 2018.
    • 12 May 2017 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2018.
    • 12 May 2017 Status changed from recruiting to suspended.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top